{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"37"}],"title":"yes"},{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"2"}],"title":"no"}],"title":"Grade 4 Neutropenia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"71"},{"groupId":"OG001","value":"37"}],"title":"yes"},{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"2"}],"title":"no"}],"title":"Grade 3 Neutropenia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"37"}],"title":"yes"},{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"2"}],"title":"no"}],"title":"Grade 2 Neutropenia"}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"description":"The number of subjects with grade 2, 3 and 4 neutropenia will be recorded for all 4 chemotherapy cycles.","groups":[{"description":"F-627, 20 mg fixed dose pre-filled syringe, dosed Day 2 of each of 4 chemotherapy cycles.","id":"OG000","title":"F-627"},{"description":"Placebo, pre-filled syringe administered Day 2 of the first chemotherapy cycle; and F-627, 20 mg fixed dose pre-filled syringe administered Day 2 of each of the following 3 chemotherapy cycles.","id":"OG001","title":"Placebo"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"4 chemotherapy cycles, about 12 weeks","title":"Number of Participants With Grade 2, Grade 3, and Grade 4 Neutropenia for All Chemotherapy Cycles.","type":"SECONDARY","unitOfMeasure":"Participants"}